NCT00675064View on ClinicalTrials.gov

Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

May 2, 2008

Primary Completion Date

October 12, 2008

Study Completion Date

October 12, 2008

Conditions

Malaria

Interventions

DRUG

GSK369796

Anti-malarial

DRUG

Placebo

Placebo matching GSK369796

Trial Locations (1)

NW10 7NS

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

collaborator

Medicines for Malaria Venture

OTHER

lead

GlaxoSmithKline

INDUSTRY

NCT00675064 - Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects | Biotech Hunter | Biotech Hunter